Browsing by Subject "Cancer"

Now showing 1 - 3 of 3

An in vitro and in silico study of antioxidant properties of curcuminoid N-alkylpyridinium salts: Initial assessment of their antitumoral properties
(2022) Forero-Doria, Oscar; Guzmán, Luis; Jiménez-Aspee, Felipe; Echeverría, Javier; Wehinger, Sergio; Valenzuela, Claudio; Araya-Maturana, Ramiro; Martínez-Cifuentes, Maximiliano
In this work, we report the synthesis of curcuminoids with ionic liquid characteristics, obtained by incorporating alkyl-substituted pyridinium moiety rather than one phenyl group through a two-step process. The antioxidant capacity of the obtained compounds was evaluated in vitro by 1,1-diphenyl-picrylhydrazyl (DPPH) free radical scavenging and ferric reducing antioxidant power (FRAP) assays, showing that some derivatives are more potent than curcumin. Pyridine curcuminoids (group 4) and curcuminoid N-alkylpyridinium salts with two methoxyl groups in the phenyl ring (group 7), presented the best antioxidant capacity. The experimental results were rationalized by density functional theory (DFT) calculations of the bond dissociation enthalpy (BDE) for O–H in each compound. The computational calculations allowed for insight into the structural–antioxidant properties relationship in these series of compounds. BDEs, obtained in the gas phase and water, showed a notable impact of water solvation on the stabilization of some radicals. The lower values of BDEs in the water solution correspond to the structurally related compounds curcuminoid-pyridine 4c and curcuminoid pyridinium salt 7a, which is consistent with the experimental results. Additionally, an assessment of cell viability and cell migration assays was performed for human colon cancer (HT29), human breast cancer (MCF7) cells, in addition to NIH3T3 murine fibroblast, as a model of non-cancer cell type. These compounds mainly cause inhibition of the cell migration observed in MCF7 cancer cells without affecting the non-tumoral NIH3T3 cell line: Neither in viability nor in migration.
Mangelernährung bei Tumorpatienten unter Chemotherapie : Anwendung und Weiterentwicklung eines computergestützten Programmes zur Erfassung und Vorhersage des Ernährungsstatus onkologischer Patienten
(2012) Renger, Sebastian; Biesalski, Hans-Konrad
Malnutrition is a serious problem in the health care of cancer in- and outpatients. Especially for outpatients there is little information on their nutritional status available, because nutritional screenings are not often used, although there is plenty of them accessible. The workgroup of Professor Biesalski developed a software, called oncoMAT, to calculate the current and the prospective nutritional status of tumour patients. Patient data of cancer patients from Tübingen and Freiburg were collected and analysed to test the program. For comparison the gold standard SGA (Suvjective Global Assessment) was used. Anthropometry, BIA, blood analysis and patient questioning about adverse events were used to evaluate the nutritional status as well. Results were checked for specificity and sensitivity. The Risk-Score statements were evaluated considering different model-conditions. To calculate the prognostic score, patient- and illnessrelated parameters were proved by a variance analysis and a multiple linear regression.
NOD1 cooperates with HAX‐1 to promote cell migration in a RIPK2‐ and NF‐ĸB‐independent manner
(2023) Hezinger, Lucy; Bauer, Sarah; Ellwanger, Kornelia; Piotrowsky, Alban; Biber, Felix; Venturelli, Sascha; Kufer, Thomas A.
The human Nod-like receptor protein NOD1 is a well-described pattern-recognition receptor (PRR) with diverse functions. NOD1 associates with F-actin and its protein levels are upregulated in metastatic cancer cells. A hallmark of cancer cells is their ability to migrate, which involves actin remodelling. Using chemotaxis and wound healing assays, we show that NOD1 expression correlated with the migration rate and chemotactic index in the cervical carcinoma cell line HeLa. The effect of NOD1 in cell migration was independent of the downstream kinase RIPK2 and NF-ĸB activity. Additionally, NOD1 negatively regulated the phosphorylation status of cofilin, which inhibits actin turnover. Co-immunoprecipitation assays identified HCLS1-associated protein X-1 (HAX-1) as a previously unknown interaction partner of NOD1. Silencing of HAX-1 expression reduced the migration behaviour to similar levels as NOD1 knockdown, and simultaneous knockdown of NOD1 and HAX-1 showed no additive effect, suggesting that both proteins act in the same pathway. In conclusion, our data revealed an important role of the PRR NOD1 in regulating cell migration as well as chemotaxis in human cervical cancer cells and identified HAX-1 as a protein that interacts with NOD1 and is involved in this signalling pathway.